These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29861165)

  • 21. In Vitro Pluripotent Stem Cell Differentiation to Hepatocyte Ceases Further Maturation at an Equivalent Stage of E15 in Mouse Embryonic Liver Development.
    Raju R; Chau D; Notelaers T; Myers CL; Verfaillie CM; Hu WS
    Stem Cells Dev; 2018 Jul; 27(13):910-921. PubMed ID: 29851366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
    Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
    Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
    Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
    Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells.
    Wang Y; Alhaque S; Cameron K; Meseguer-Ripolles J; Lucendo-Villarin B; Rashidi H; Hay DC
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28287600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional cultured liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells.
    Kamei KI; Yoshioka M; Terada S; Tokunaga Y; Chen Y
    Biomed Microdevices; 2019 Jul; 21(3):73. PubMed ID: 31304567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure.
    Liu QW; Liu QY; Li JY; Wei L; Ren KK; Zhang XC; Ding T; Xiao L; Zhang WJ; Wu HY; Xin HB
    Stem Cell Res Ther; 2018 Nov; 9(1):321. PubMed ID: 30463600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 Genome Engineering in Human Pluripotent Stem Cells for Modeling of Neurological Disorders.
    Canals I; Ahlenius H
    Methods Mol Biol; 2021; 2352():237-251. PubMed ID: 34324191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate.
    Pistoni M; Helsen N; Vanhove J; Boon R; Xu Z; Ordovas L; Verfaillie CM
    PLoS One; 2017; 12(11):e0186884. PubMed ID: 29091973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.
    Chang Y; Hellwarth PB; Randolph LN; Sun Y; Xing Y; Zhu W; Lian XL; Bao X
    Biotechnol Bioeng; 2020 Jul; 117(7):2177-2186. PubMed ID: 32277708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes.
    Sinton MC; Meseguer-Ripolles J; Lucendo-Villarin B; Drake AJ; Hay DC
    STAR Protoc; 2021 Jun; 2(2):100493. PubMed ID: 33997813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
    Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
    Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix.
    Kanninen LK; Porola P; Niklander J; Malinen MM; Corlu A; Guguen-Guillouzo C; Urtti A; Yliperttula ML; Lou YR
    Exp Cell Res; 2016 Feb; 341(2):207-17. PubMed ID: 26854693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
    Kondo Y; Iwao T; Yoshihashi S; Mimori K; Ogihara R; Nagata K; Kurose K; Saito M; Niwa T; Suzuki T; Miyata N; Ohmori S; Nakamura K; Matsunaga T
    PLoS One; 2014; 9(8):e104010. PubMed ID: 25084468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.
    Phelps MP; Bailey JN; Vleeshouwer-Neumann T; Chen EY
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15090-15095. PubMed ID: 27956629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
    Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for scarless genome editing of human pluripotent stem cell based on orthogonal selective reporters.
    Zhao Y; Pan Z; Hong Z; Sun M; Hong Y; Peng X; Li X; Wang X; Wang K
    STAR Protoc; 2024 Jun; 5(2):103084. PubMed ID: 38787727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.
    Nagaoka M; Kobayashi M; Kawai C; Mallanna SK; Duncan SA
    PLoS One; 2015; 10(8):e0136350. PubMed ID: 26308339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells.
    Kearns NA; Genga RM; Enuameh MS; Garber M; Wolfe SA; Maehr R
    Development; 2014 Jan; 141(1):219-23. PubMed ID: 24346702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.